(2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid(CAS: 22688-78-4)

The regulatory guidelines for (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) include REACH regulations covering environmental, health, and safety aspects. Additionally, FDA and EPA guidelines may apply due to its potential use in pharmaceuticals and environmental applications. Proper handling, storage, and disposal should comply with local and international regulations.

There are several alternatives to (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid in synthesis. Common alternatives include related chroman-3-ol derivatives and similar cyclic polyhydroxy compounds. These can be synthesized using different reagents and conditions, providing flexibility in chemical synthesis.

The market trend for (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) shows increasing interest in its use in pharmaceuticals and natural product chemistry. Research trends focus on its potential biological activities and applications in drug discovery. Market demand is driven by its unique chemical structure and pharmaceutical properties.

Waste containing (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) should be collected in appropriate containers and stored under controlled conditions to prevent degradation and environmental release. Waste should be disposed of through incineration or professional waste disposal services. Environmental protection measures must be adhered to, including proper labeling and documentation of waste management practices.